Search clinical trials for: Multiple (Four Weekly) Subcutaneous Injections (Part B) of PB1023 or Placebo (0.9% NaCl)
Total 8 results
-
PhaseBio Pharmaceuticals Inc.Completed
-
PhaseBio Pharmaceuticals Inc.Completed
-
University Hospital, BrestMinistry of Health, FranceCompleted
-
Dompé Farmaceutici S.p.ACovanceCompletedHealthySwitzerland, United Kingdom
-
Praxis Precision MedicinesRecruitingSCN2A Encephalopathy | SCN8A EncephalopathyUnited States, Spain
-
U.S. Army Medical Research and Development CommandWalter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation...Active, not recruitingSARS-CoV-2 InfectionUnited States
-
AmgenCompletedRheumatoid ArthritisUnited States, Germany, Italy, Mexico, France, Canada, Hungary, Portugal, Spain, Greece, Bulgaria, Czechia, Poland, Argentina, South Africa
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityTerminatedPrimary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditionsUnited States